Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202607643375797Phase 2Recruiting
Phase 2, randomised, open-label trial of acetylcysteine in acetaminophen poisoning (2 arms), sponsored by Self sponsor. Primary endpoint: Incidence of hepatotoxicity. Started Nov 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202607643375797.